FDA approves Novo Nordisk weight-loss pill. Here’s what to know

The U.S. Food and Drug Administration approved Novo Nordisk’s weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly. The pill is 25 milligrams of semaglutide, the same active ingredient inContinueContinue reading “FDA approves Novo Nordisk weight-loss pill. Here’s what to know”

Design a site like this with WordPress.com
Get started